Samarium sm-153 lexidronam pentasodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for samarium sm-153 lexidronam pentasodium and what is the scope of freedom to operate?
Samarium sm-153 lexidronam pentasodium
is the generic ingredient in one branded drug marketed by Lantheus Medical and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for samarium sm-153 lexidronam pentasodium
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 6 |
DailyMed Link: | samarium sm-153 lexidronam pentasodium at DailyMed |
Recent Clinical Trials for samarium sm-153 lexidronam pentasodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
NRG Oncology | Phase 3 |
National Cancer Institute (NCI) | Phase 3 |
Radiation Therapy Oncology Group | Phase 3 |
See all samarium sm-153 lexidronam pentasodium clinical trials
US Patents and Regulatory Information for samarium sm-153 lexidronam pentasodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lantheus Medical | QUADRAMET | samarium sm-153 lexidronam pentasodium | INJECTABLE;INJECTION | 020570-001 | Mar 28, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for samarium sm-153 lexidronam pentasodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lantheus Medical | QUADRAMET | samarium sm-153 lexidronam pentasodium | INJECTABLE;INJECTION | 020570-001 | Mar 28, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |